Salu Launches New Disease Resource Center for Focal Dystonia


GRANITE BAY, Calif., Sept. 25 /PRNewswire/ -- Salu(R), Inc. today
announced the launch of its new Focal Dystonia Resource Center (FDRC) to
provide practical information on the use of botulinum toxin to help treat the
neurological movement disorder. The FDRC provides Salu member-neurologists
and their staff with easy access to a comprehensive collection of more than
150 peer-reviewed references and tools, including clinical summaries and
reimbursement advice. Selected clinical references and tools will soon be
available for download to a handheld device. The Focal Dystonia Resource
Center is accessible on NeuroHub(TM), the Salu Medical Specialty Hub(TM)
platform for neurologists and pain management specialists. This is the second
Disease Resource Center Salu has launched in NeuroHub this year. A market
leader in advancing the relationship among strategic partners,
physician-specialists and their patients, Salu plans to launch additional
Disease Resource Centers later this year. Salu's new Multiple Sclerosis
Resource Center has been well received by NeuroHub members since its launch in
May. The MSRC includes 600 clinical references, patient handouts, billing
advice and online CME.

"Salu remains committed to providing physician-specialists effective
online and off-line tools and services to enhance patient care," said Jim
Steeb, President and CEO of Salu. "The Focal Dystonia Resource Center is one
of the ways we provide strategic partners a direct channel to deliver unbiased
education and information to physician-specialists in a noncommercial
setting," said Mr. Steeb.

"Many neurologists are interested in using botulinum toxin, but don't know
where to begin because it is difficult to access practical information," said
Richard Trosch, MD, a Movement Disorders specialist in private practice in
Southfield, Mich. (http://rmtrosch.neurohub.net/share.html) "The Salu Focal
Dystonia Resource Center contains useful information that includes appropriate
dosing guidelines, how to prepare the toxin, the types of needles to use, how
to document injections and more. In addition, there are useful tools such as
patient handouts and billing advice," said Dr. Trosch.

The FDRC and Salu's other disease resource centers, including the
Anaphylaxis and Multiple Sclerosis resource centers, are organized into topics
relevant to the management and treatment of a specific disease, disorder or
condition and contain clinically relevant information selected by Salu and its
medical advisors through an independent review process.

Beginning in October, these services will be expanded to communicate
selected clinical references and tools in a new way, downloadable to a
handheld device. Salu's market research study conducted early this year
revealed that 52 percent of its neurologist members use a handheld device, and
an additional 28 percent plan to start using one by year-end.

Salu Disease Resource Centers provide Salu pharmaceutical partners an
objective, disease-specific channel to deliver their own clinically relevant
information and resources to physicians and patients in a noncommercial
environment. Partners are able to cost-effectively distribute: clinical
references (e.g., product monographs, journal reprints, clinical guidelines,
select textbook chapters and meeting summaries); patient education materials
(e.g., patient handouts and medication compliance programs); and CME.
E-detailing opportunities to review drug information are also available.

Today, more than 68 percent of the nation's office-based neurologists and
nearly 25,000 of their patients are enrolled in NeuroHub. Moreover, an
increasing number of the nation's allergists, cardiologists and dermatologists
use Salu services to help manage their practice and access other professional
resources.

About Salu
Salu(R), Inc. is based on the premise that physician-specialists have
distinctly different needs. Salu offers a unique Medical Specialty Hub(TM)
platform (including NeuroHub(TM) which serves neurologists and pain management
specialists, and Dermdex(R) which serves dermatologists and plastic surgeons)
that provides customized tools and services to help specialists enhance
patient care and improve their practice's effectiveness and profitability.
Salu provides strategic partners in the life sciences, pharmaceutical,
biotechnology and medical device industries with access to an organized and
efficient marketplace of specialists and their practices. In addition, Salu
offers its partners a flexible, integrated suite of services to increase
reach, frequency and share of voice among physician-specialists and their
patients.

First, Salu works with strategic partners to identify and enroll (if they
are not already enrolled) targeted physicians as Salu members and provide Salu
services. Second, Salu provides various integrated tools and services to
complement existing sales and marketing initiatives. These tools and services
include disease resource centers, partner sales and marketing resource centers
and e-detailing. Salu complements these integrated services with both online
and off-line marketing to help physicians' use of the services. Finally, Salu
measures program results to demonstrate return on investment (ROI) and to
ensure partners' satisfaction with the programs.

Salu, a privately held, profitable venture-capital-backed company
headquartered in Granite Bay, California, has partnerships with numerous life
sciences companies, including pharmaceutical, biotechnology and medical device
companies. Salu is in discussions with other companies, focusing on products
in various specialty categories including allergy, cardiology, dermatology and
neurology. Potential partners and interested physician-specialists can learn
more about Salu by visiting http://www.pharmabusiness.salu.com or calling
(888) 288-SALU (7258). Or e-mail salupharmabusiness@salu.com.